Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  CDKs/JAK2/FLT3 inhibitor TG02 citrate
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Temozolomide with or without TG02 in Treating Patients with Recurrent Anaplastic Astrocytoma, Glioblastoma, or Gliosarcoma
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 17-C-0009, NCI-2016-01621, NCT02942264
Start Over